Wang Fangyuan, Zhao Dehua, Qi Lei Stanley
Sino-U.S. Center of Synthetic Biology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
Department of Bioengineering, Stanford University, CA 94305, USA.
Sheng Wu Gong Cheng Xue Bao. 2017 Mar 25;33(3):422-435. doi: 10.13345/j.cjb.160420.
Synthetic biology aims to establish a complete set of engineering principles, theories, and methods, via the rational design and assembly of basic biological parts, for the goal of effective implementation of complex biological systems with programmable functions. In recent years, with emerging novel classes of programmable genetic parts, in particular, the establishment and optimization of CRISPR and CRISPRi technology platforms, synthetic biology is entering a new era. This review summarizes recent advances on CRISPR genome editing and gene regulation technologies, their applications in constructing programmable biological parts, and their roles in building sophisticated gene circuits. We also provide a future vision on how synthetic biology can transform medicine (named medical synthetic biology, MSB) and therapeutics.
合成生物学旨在通过对基本生物部件进行合理设计和组装,建立一套完整的工程原理、理论和方法,以实现具有可编程功能的复杂生物系统。近年来,随着新型可编程遗传部件的出现,特别是CRISPR和CRISPRi技术平台的建立和优化,合成生物学正进入一个新时代。本文综述了CRISPR基因组编辑和基因调控技术的最新进展、它们在构建可编程生物部件中的应用以及在构建复杂基因回路中的作用。我们还对合成生物学如何变革医学(称为医学合成生物学,MSB)和治疗方法提出了未来展望。